BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2155795)

  • 1. MK-801 potently inhibits alcohol withdrawal seizures in rats.
    Morrisett RA; Rezvani AH; Overstreet D; Janowsky DS; Wilson WA; Swartzwelder HS
    Eur J Pharmacol; 1990 Jan; 176(1):103-5. PubMed ID: 2155795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol withdrawal seizures and the NMDA receptor complex.
    Grant KA; Valverius P; Hudspith M; Tabakoff B
    Eur J Pharmacol; 1990 Feb; 176(3):289-96. PubMed ID: 2158451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor antagonists inhibit kindling epileptogenesis and seizure expression in developing rats.
    Trommer BL; Pasternak JF
    Brain Res Dev Brain Res; 1990 May; 53(2):248-52. PubMed ID: 2162746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
    Schmidt WJ; Bubser M
    Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
    Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
    Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures.
    Liljequist S
    Eur J Pharmacol; 1991 Jan; 192(1):197-8. PubMed ID: 1674917
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
    Kulkarni SK; Ticku MK
    Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.
    McNamara JO; Russell RD; Rigsbee L; Bonhaus DW
    Neuropharmacology; 1988 Jun; 27(6):563-8. PubMed ID: 2843782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model.
    Stasheff SF; Anderson WW; Clark S; Wilson WA
    Science; 1989 Aug; 245(4918):648-51. PubMed ID: 2569762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of N-methyl-D-aspartate (NMDA) antagonist MK-801 on breathing pattern in rats.
    Monteau R; Gauthier P; Rega P; Hilaire G
    Neurosci Lett; 1990 Feb; 109(1-2):134-9. PubMed ID: 2156189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorazepam and MK-801 effects on behavioral and electrographic indices of alcohol withdrawal sensitization.
    Veatch LM; Becker HC
    Brain Res; 2005 Dec; 1065(1-2):92-106. PubMed ID: 16313888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures.
    Kotlinska J; Liljequist S
    Psychopharmacology (Berl); 1996 Oct; 127(3):238-44. PubMed ID: 8912402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of MK-801 on the micturition reflex in anesthetized rats.
    Maggi CA; Giuliani S; Giachetti A; Meli A
    Eur J Pharmacol; 1990 May; 181(1-2):105-9. PubMed ID: 2167227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME
    Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats.
    Vezzani A; Serafini R; Stasi MA; Caccia S; Conti I; Tridico RV; Samanin R
    J Pharmacol Exp Ther; 1989 Apr; 249(1):278-83. PubMed ID: 2540317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-801 protects against seizures induced by the cholinesterase inhibitor soman.
    Braitman DJ; Sparenborg S
    Brain Res Bull; 1989; 23(1-2):145-8. PubMed ID: 2553217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of MK-801 on kindled seizures: implications for use and limitations as an antiepileptic drug.
    Williamson JM; Lothman EW
    Ann Neurol; 1989 Jul; 26(1):85-90. PubMed ID: 2549848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.